Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis
Primary Purpose
Knee Osteoarthritis
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Reparel Knee Sleeve
Sponsored by
About this trial
This is an interventional treatment trial for Knee Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- osteoarthritis visible on knee radiograph
- patient opting for non-surgical treatment
- no corticosteroid knee injection for 90 days prior to consent
- no corticosteroid knee injection for 90 days following consent
Exclusion Criteria:
- bilateral symptomatic knee osteoarthritis
- prior surgery on the knee of interest
- hardware present on the knee of interest
- gross instability detected on physical exam
- malignancy in the knee of question
Sites / Locations
- UAB Hospital Highlands
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Reparel Sleeve Group
Arm Description
Patients receiving reparel knee sleeve for treatment of knee osteoarthritis.
Outcomes
Primary Outcome Measures
University of California, Los Angeles (UCLA) Activity Score
activity score, 1-10, 10 is best outcome
Lysholm Score
ability to manage activities of daily living, 0-100, 100 is best outcome
Oxford Knee Score (OKS)
knee pain and function score, 0-48, 48 is best outcome
Knee Injury and Osteoarthritis Outcome Score (KOOS)
knee pain and function score, 0-100, 100 is best outcome
Single Assessment Numeric Evaluation (SANE)
function score, 0-100%, 100% is best outcome
Visual Analog Scale (VAS)
pain score, 0-10, 10 is best outcome
Secondary Outcome Measures
Full Information
NCT ID
NCT04743921
First Posted
February 3, 2021
Last Updated
August 4, 2023
Sponsor
University of Alabama at Birmingham
1. Study Identification
Unique Protocol Identification Number
NCT04743921
Brief Title
Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis
Official Title
Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
January 6, 2024 (Anticipated)
Study Completion Date
June 6, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a belief that anti-inflammatory sleeve technology may be beneficial in treating knee OA. The purpose of this study is to determine the clinical effects of Reparel™ knee sleeve regarding mobility, functionality, and pain outcomes in managing knee OA.
Detailed Description
Standard knee compression sleeves have been described throughout literature to provide benefits in pain and functional outcomes through support of the ligamentous structures. Bracing is both an effective and economical treatment for osteoarthritis and serves as a crucial option in the treatment of knee OA to aid in both delaying surgery and as options for young patients, or patients that are not ideal surgical candidates. Although knee sleeves are commonly utilized treatment modalities, there is a significant paucity of literature on the effects of thermo-active braces in the treatment of knee OA. This investigation will examine this non-operative treatment modality and study it effect for the treatment of knee OA specifically by investigating the Reparel Knee Sleeve. The Reparel Knee Sleeve is a Class I Medical Device (510(k) exempt) and used in general sports medicine practice for the alleviation of knee pain. The authors expect that the Reparel thermos-active knee sleeve will have a significant effect on pain relief from knee OA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Reparel Sleeve Group
Arm Type
Experimental
Arm Description
Patients receiving reparel knee sleeve for treatment of knee osteoarthritis.
Intervention Type
Device
Intervention Name(s)
Reparel Knee Sleeve
Intervention Description
Patients who are recommended for non-operative management of knee osteoarthritis and have been consented in clinic to participate in the study will be given a Reparel™ knee sleeve to wear for knee osteoarthritis management. Each device will be numbered and recorded in the patient's REDCap entry for future reference if needed. Following administration of the Reparel™ knee sleeve, patients will be given instructions on how to use/wear the sleeve while performing activities of daily living or sports that had previously resulted in knee pain and also be asked to do the follows: wear the sleeve as much as they possibly can; not change their usual activities and diet during the time they are on this study; record in a diary the number of hours sleeve was worn per day; record any adverse effects or discomfort due to sleeve use; refrain from altering treatment for knee osteoarthritis.
Primary Outcome Measure Information:
Title
University of California, Los Angeles (UCLA) Activity Score
Description
activity score, 1-10, 10 is best outcome
Time Frame
3 months
Title
Lysholm Score
Description
ability to manage activities of daily living, 0-100, 100 is best outcome
Time Frame
3 months
Title
Oxford Knee Score (OKS)
Description
knee pain and function score, 0-48, 48 is best outcome
Time Frame
3 months
Title
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Description
knee pain and function score, 0-100, 100 is best outcome
Time Frame
3 months
Title
Single Assessment Numeric Evaluation (SANE)
Description
function score, 0-100%, 100% is best outcome
Time Frame
3 months
Title
Visual Analog Scale (VAS)
Description
pain score, 0-10, 10 is best outcome
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
osteoarthritis visible on knee radiograph
patient opting for non-surgical treatment
no corticosteroid knee injection for 90 days prior to consent
no corticosteroid knee injection for 90 days following consent
Exclusion Criteria:
bilateral symptomatic knee osteoarthritis
prior surgery on the knee of interest
hardware present on the knee of interest
gross instability detected on physical exam
malignancy in the knee of question
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amit Momaya, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
UAB Hospital Highlands
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35205
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis
We'll reach out to this number within 24 hrs